In particular, a study linking COVID-19 and CH showed an increased inflammatory response from monocytes in severe COVID-19 patients with CH, mediated via interferon gamma (IFN-γ) and TNF-α signaling signatures (Choi et al., 2022). The gene discussed is IFNG; the disease is COVID-19.